Autobio Diagnostics released its 2026 half-year report. Net profit attributable to the parent in the first half was 497 million yuan, down 12.9% year on year. Operating revenue was 2.06 billion yuan, down 0.1% year on year. Net profit attributable to the parent after deducting non-recurring items was 493 million yuan, down 9.7% year on year. Net operating cash flow was 216 million yuan, down 47.4% year on year. In the second quarter, operating revenue was 1.07 billion yuan, up 0.1% year on year, and net profit attributable to the parent was 261 million yuan, down 13.4% year on year. Research and development expenses in the first half reached 302 million yuan, accounting for 14.68% of operating revenue. The company's products have entered more than 120 countries and regions in overseas markets.
Autobio Diagnostics Co LtdFirst-half net profit fell 12.9% year on year, with operating cash flow down 47.4%.
